• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高龄不是大肝癌行肝切除术的禁忌证。

Advanced age is not a contraindication for liver resection in cases of large hepatocellular carcinoma.

机构信息

Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

出版信息

Eur J Surg Oncol. 2014 Feb;40(2):214-9. doi: 10.1016/j.ejso.2013.10.016. Epub 2013 Nov 5.

DOI:10.1016/j.ejso.2013.10.016
PMID:24316111
Abstract

BACKGROUND

The role of surgery in the management of large hepatocellular carcinomas (HCCs) is controversial. Advanced age and comorbidities are taken into account when major surgery is considered.

PURPOSE

To compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) for resectable HCC in patients aged 70 years or older.

PATIENTS AND MATERIALS

This study included 70 patients aged 70 years or older treated for large HCCs (≥5 cm) between January 2007 and December 2012: 37 underwent LR and 33 underwent TACE. The outcomes of these patients were retrospectively analyzed. Univariate and multivariate Cox proportional hazard models were established. Kaplan-Meier survival curves were generated, and survival data were compared using the log-rank test.

RESULTS

Hospital stay was significantly longer in the LR group than in the TACE group (10 days vs 8.5 days; P = 0.003). Treatment-related complications were more frequent in the TACE group, but this difference was not statistically significant. LR was associated with a better disease-free survival rate, median survival rate and cumulative overall survival rate.

CONCLUSION

Our results showed that LR could be a safe and effective treatment option for HCC tumors ≥5 cm in patiets aged 70 years or older.

摘要

背景

手术在大肝细胞癌(HCC)治疗中的作用存在争议。在考虑进行大手术时,会考虑到高龄和合并症。

目的

比较肝切除术(LR)和经动脉化疗栓塞术(TACE)治疗 70 岁及以上可切除 HCC 的效果。

患者和材料

本研究纳入 2007 年 1 月至 2012 年 12 月期间治疗的 70 名 70 岁及以上的大 HCC(≥5cm)患者:37 例行 LR,33 例行 TACE。回顾性分析这些患者的结局。建立单变量和多变量 Cox 比例风险模型。生成 Kaplan-Meier 生存曲线,并使用对数秩检验比较生存数据。

结果

LR 组的住院时间明显长于 TACE 组(10 天 vs 8.5 天;P = 0.003)。TACE 组治疗相关并发症更常见,但差异无统计学意义。LR 与更好的无病生存率、中位生存率和累积总生存率相关。

结论

我们的结果表明,LR 可能是 70 岁及以上 HCC 肿瘤≥5cm 患者的安全有效的治疗选择。

相似文献

1
Advanced age is not a contraindication for liver resection in cases of large hepatocellular carcinoma.高龄不是大肝癌行肝切除术的禁忌证。
Eur J Surg Oncol. 2014 Feb;40(2):214-9. doi: 10.1016/j.ejso.2013.10.016. Epub 2013 Nov 5.
2
The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.可切除肝细胞癌术前经动脉化疗栓塞对临床及经济结局的影响。
J Surg Oncol. 2009 May 1;99(6):343-50. doi: 10.1002/jso.21248.
3
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.术前经导管肝动脉化疗栓塞对肝细胞癌肝切除术后无病生存期的影响。
Cancer. 2000 Dec 15;89(12):2606-12.
4
Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.术前经动脉化疗栓塞联合切除术治疗肝细胞癌:一项基于全台湾数据库的长期预后预测因素分析。
J Surg Oncol. 2014 Apr;109(5):487-93. doi: 10.1002/jso.23521. Epub 2013 Nov 30.
5
Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.BCLC A期孤立性大肝细胞癌患者肝切除术后与经动脉化疗栓塞术后长期生存率的比较:一项倾向评分分析
PLoS One. 2014 Dec 26;9(12):e115834. doi: 10.1371/journal.pone.0115834. eCollection 2014.
6
[Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].[米兰标准内肝细胞癌肝切除与经动脉化疗栓塞术的比较]
Zhonghua Yi Xue Za Zhi. 2014 May 27;94(20):1526-9.
7
[Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].[58例经肝动脉化疗栓塞术降期后大肝细胞癌的治疗体会]
Zhonghua Yi Xue Za Zhi. 2011 Apr 12;91(14):950-5.
8
Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.肝切除术与经动脉碘油化疗栓塞作为大、多发且可切除肝癌的初始治疗:一项前瞻性非随机分析。
Radiology. 2011 Apr;259(1):286-95. doi: 10.1148/radiol.10101072. Epub 2011 Feb 17.
9
Role of surgical resection for multiple hepatocellular carcinomas.外科切除术治疗多个肝细胞癌的作用。
World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.
10
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.优化BCLC B期肝细胞癌患者的管理:现代手术切除作为经动脉化疗栓塞的可行替代方案。
Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12.

引用本文的文献

1
Editorial on "".关于“”的社论。
Hepatobiliary Surg Nutr. 2022 Aug;11(4):580-582. doi: 10.21037/hbsn-22-297.
2
Short-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma in older patients: a propensity score matching analysis.腹腔镜与开腹肝切除术治疗老年肝细胞癌的短期疗效:倾向评分匹配分析。
BMC Surg. 2022 Feb 23;22(1):63. doi: 10.1186/s12893-022-01518-x.
3
SURGICAL MANAGEMENT OF LARGE HEPATOCELLULAR CARCINOMA: THE FIRST SINGLE-CENTER STUDY FROM WESTERN INDIA.大肝细胞癌的外科治疗:来自印度西部的首个单中心研究
Arq Bras Cir Dig. 2020 Jul 28;33(2):e1505. doi: 10.1590/0102-672020190001e1505. eCollection 2020.
4
Preoperative survival calculator for resectable hepatocellular carcinoma.可切除肝细胞癌的术前生存计算器
J Gastrointest Oncol. 2018 Apr;9(2):316-325. doi: 10.21037/jgo.2017.12.03.
5
Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.肝切除术与经动脉化疗栓塞术用于肝细胞癌的初始治疗:一项系统评价和荟萃分析
Oncotarget. 2015 Jul 30;6(21):18715-33. doi: 10.18632/oncotarget.4134.
6
Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.肝细胞癌的生存分析:年轻患者与老年患者的比较
Chin Med J (Engl). 2015 Jul 5;128(13):1793-800. doi: 10.4103/0366-6999.159356.